Market Tracker

03/30 6:24am ET

NxStage Medical Inc (NASDAQ:NXTM)

17.03
Delayed Data
As of Mar 27
 +0.19 / +1.13%
Today’s Change
10.69
Today|||52-Week Range
19.19
-5.02%
Year-to-Date

Today’s Trading

Previous close16.84
Today’s open16.83
Day’s range16.71 - 17.09
Volume324,095
Average volume (3 months)417,474
Market cap$1.1B
Dividend yield--
Data as of 03/27/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+5.13%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...+0.63+4.23%
BRLIBio-Reference Labora...+0.52+1.50%
DBVTDBV Technologies SA-0.19-0.82%
KERXKeryx Biopharmaceuti...-0.08-0.63%
Data as of 03/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Jeffrey H. Burbank
Senior Vice President-
Manufacturing Operations
Thomas F. Shea
Corporate headquarters
Lawrence, Massachusetts

Forecasts